Aclaris Therapeutics Inc (NASDAQ:ACRS)
| 16.82 Delayed Data As of Jan 26 |  +0.05 / +0.30%Today’s Change | 9.84 Today|||52-Week Range 18.96 | +6.79% Year-to-Date |
Latest ACRS News | Press Releases
No recent news for Aclaris Therapeutics Inc.
Today’s Trading
| Previous close | 16.77 |
| Today’s open | 16.95 |
| Day’s range | 16.59 - 17.10 |
| Volume | 290,232 |
| Average volume (3 months) | 349,761 |
| Market cap | $1.1B |
Data as of 3:59pm ET, 01/26/2023
Growth & Valuation
| Earnings growth (last year) | -33.56% |
| Earnings growth (this year) | +10.17% |
| Earnings growth (next 5 years) | +38.60% |
| Revenue growth (last year) | +4.30% |
| P/E ratio | NM |
| Price/Sales | 122.00 |
| Price/Book | 5.13 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CRNXCrinetics Pharmaceut... | -1.13 | -5.36% |
| TAROTaro Pharmaceutical ... | -0.01 | -0.03% |
| ---- | ||
| ENTAEnanta Pharmaceutica... | +0.02 | +0.04% |
Data as of 4:00pm ET, 01/26/2023
Financials
| Next reporting date | March 14, 2023 |
| EPS forecast (this quarter) | -$0.45 |
| Annual revenue (last year) | $6.8M |
| Annual profit (last year) | -$90.9M |
| Net profit margin | -1,343.96% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Wayne, Pennsylvania |
Forecasts
